Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer

Clinical trial NCT02697838 · UNKNOWN

Trial details

NCT number: NCT02697838
Sponsor: Fujian Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Neoplasm of Stomach Stage II

Start date: 2016-08-01
Primary completion: 2018-03-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.